Skip to main content

Table 2 The comparing of serum lipid levels and dyslipidemia rates of gastric cancer group and control group

From: Biomarkers of lipid metabolism in gastric cancer: a case control study

 

Total

Male

Female

GC*

Control

t/ x2

P

GC

Control

t/ x2

P

GC

Control

t/ x2

P

TG(mmol/L)#

1.409 ± 0.933

1.329 ± 1.055

1.902

0.047

1.367 ± 0.894

1.373 ± 1.085

0.116

0.907

1.522 ± 0.059

1.214 ± 0.055

3.836

< 0.001

TC(mmol/L) #

4.945 ± 1.177

4.862 ± 1.021

1.755

0.076

4.825 ± 1.026

4.782 ± 0.998

0.851

0.395

5.268 ± 1.467

5.072 ± 1.052

1.897

0.058

HDL(mmol/L) #

1.332 ± 0.687

1.423 ± 0.354

3.959

< 0.001

1.267 ± 0.706

1.349 ± 0.337

2.991

0.003

1.508 ± 0.598

1.620 ± 0.319

2.876

0.004

LDL(mmol/L) #

3.045 ± 1.034

2.812 ± 0.854

5.836

< 0.001

2.997 ± 1.052

2.768 ± 0.835

4.884

< 0.001

3.177 ± 0.974

2.930 ± 0.891

3.381

0.001

TG(n,%)&

225(20.1%)

265(23.4%)

3.562

0.066

149(18.2%)

206(25.1%)

11.328

0.001

76(25.2%)

59(18.9%)

3.501

0.065

TC(n,%)&

417(37.2%)

407(35.9%)

0.437

0.512

272(33.3%)

269(32.7%)

0.051

0.834

145(48.0%)

138(44.2%)

0.884

0.373

HDL(n,%)&

179(16.0%)

129(11.4%)

10.135

0.002

138(16.9%)

105(12.8%)

5.452

0.022

41(13.6%)

24(7.7%)

5.613

0.019

LDL(n,%)&

452(40.4%)

384(33.9%)

10.186

0.001

311(38.0%)

254(30.9%)

9.202

0.003

141(46.7%)

130(41.7%)

1.570

0.223

  1. *GC: gastric cancer group; # continuous variable compared by t test; & categorical variable compared by x2 test and fisher’s exact test